It has been previously demonstrated that the oncogenes BCL/ABL in chronic myelogenous leukemia [16] and HER3 in breast cancer [17, 18] regulated NKG2D ligands expression via PI3K/AKT signalling. Here, KLRK1 is linked to breast carcinoma.